Received Jan 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
few days before getting the second one I broke out with shingles; This happened several times over the period of about 3 years and finally I got the second shot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, not applicable after receiving Shingles vaccine and an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: few days before getting the second one I broke out with shingles) and drug dose administration interval too long (Verbatim: This happened several times over the period of about 3 years and finally I got the second shot). The outcome of the shingles was not reported and the outcome of the drug dose administration interval too long was not applicable. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 27-DEC-2025 This case was reported by a patient via interactive digital media. The patient said that get the vaccine as soon as possible. The patient finally got the first vaccine and a few days before getting the second one broke out with shingles. This happened several times over the period of about 3 years and finally got the second shot, did not wait until it was too late. The batch number was not provided and we and unable to contact the reporter.